Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Agenerase 50mg capsules
0503010I0BBABAB
|
Agenerase | Amprenavir | Infections | No data available |
|
Aknemin 100mg capsules
0501030P0BDABAE
|
Aknemin | Minocycline hydrochloride | Infections | No data available |
|
Aknemin 50 capsules
0501030P0BDAAAD
|
Aknemin | Minocycline hydrochloride | Infections | No data available |
|
Alexi 3g granules for oral solution sachets
0501070AEBDAAAD
|
Alexi | Fosfomycin trometamol | Infections | No data available |
|
Almodan 125mg/5ml syrup
0501013B0BDABAJ
|
Almodan | Amoxicillin | Infections | No data available |
|
Amantadine 100mg tablets
0503040C0AAABAB
|
Amantadine hydrochloride (Antiviral) | Amantadine hydrochloride | Infections | No data available |
|
AmBisome Liposomal powder for dispersion for inf vials
0502030A0BDAAAI
|
AmBisome | Amphotericin | Infections | No data available |
|
Amiclav 250mg/125mg tablets
0501013K0BCAAAA
|
Amiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Amikacin 500mg/2ml solution for injection vials
0501040C0AAAAAA
|
Amikacin (Parenteral) | Amikacin | Infections | No data available |
|
Amikin 100mg/2ml solution for injection vials
0501040C0BBACAD
|
Amikin | Amikacin | Infections | No data available |
|
Amikin 500mg/2ml solution for injection vials
0501040C0BBAAAA
|
Amikin | Amikacin | Infections | No data available |
|
Aminosalicylic acid gast res gran 4g sachets sugar free
0501090A0AAAAAA
|
Aminosalicylic acid | Aminosalicylic acid | Infections | No data available |
|
Amix 125 oral suspension
0501013B0BFAGAS
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 250 capsules
0501013B0BFAEAA
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 250 oral suspension
0501013B0BFAIAT
|
Amix | Amoxicillin | Infections | No data available |
|
Amix 500 capsules
0501013B0BFAFAB
|
Amix | Amoxicillin | Infections | No data available |
|
Amoram 125mg/5ml oral suspension
0501013B0BGACAS
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 250mg capsules
0501013B0BGAAAA
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 250mg/5ml oral suspension
0501013B0BGADAT
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 500mg capsules
0501013B0BGABAB
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoxident 250 capsules
0501013B0BRAAAA
|
Amoxident | Amoxicillin | Infections | No data available |
|
Amoxident 500 capsules
0501013B0BRABAB
|
Amoxident | Amoxicillin | Infections | No data available |
|
Amoxil 125mg/5ml syrup sucrose free
0501013B0BCAEAS
|
Amoxil (Systemic) | Amoxicillin | Infections | No data available |
|
Amoxil 1g powder for solution for injection vials
0501013C0BCACAE
|
Amoxil (Parenteral) | Amoxicillin sodium | Infections | No data available |
|
Amoxil 250mg capsules
0501013B0BCAAAA
|
Amoxil (Systemic) | Amoxicillin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.